Genetically engineered antibody molecules: new tools for cancer therapy (Q39644773)

13 September 2017

1 reference

title

Genetically engineered antibody molecules: new tools for cancer therapy (English)

1 reference

13 September 2017

Morrison SL

1 reference

13 September 2017

Wims LA

series ordinal

1 reference

13 September 2017

Oi VT

series ordinal

1 reference

13 September 2017

publication date

1 January 1988

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

185-192

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Biological and Clinical Implications of Lymphocyte Hybridomas: Tumor Therapy with Monoclonal Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Properties of a human immunoglobulin epsilon-chain fragment synthesized in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Expression of human immunoglobulin E epsilon chain cDNA in E. coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Expression of a biologically active fragment of human IgE epsilon chain in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised inE. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Regulated expression of an immunoglobulin kappa gene introduced into a mouse lymphoid cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Immunoglobulin gene expression in transformed lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Plasmid-Determined Resistance to Antimicrobial Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

The inhibition of nucleic acid synthesis by mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Myeloma with multiple rearranged immunoglobulin kappa genes: only one kappa gene codes for kappa chains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

A hapten-specific chimaeric IgE antibody with human physiological effector function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Tolerance to rat monoclonal antibodies. Implications for serotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Replacing the complementarity-determining regions in a human antibody with those from a mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Production of functional chimaeric mouse/human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

Recombinant antibodies possessing novel effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357908809077046

10.3109/07357908809077046

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference